Trial intelligence / Profile preview

Dichlorphenamide for Periodic Paralyses

NCT00004802Phase 3Completed

Sponsor
National Center for Research Resources
Start
Jun 1992
Modality
Small Molecules
01

Overview

A Phase 3 trial of dichlorphenamide in hyperkalemic periodic paralysis (HyperKPP), paramyotonia congenita (PMC), hypokalemic periodic paralysis (HypoPP), sponsored by National Center for Research Resources. Started Jun 1992; status: completed.

02

Drugs

dichlorphenamide
03

Conditions

hyperkalemic periodic paralysis (HyperKPP)paramyotonia congenita (PMC)hypokalemic periodic paralysis (HypoPP)

Beyond the preview

Go deeper on NCT00004802.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00004802.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call